Sagespring Wealth Partners LLC Takes $244,000 Position in The Cooper Companies, Inc. (NASDAQ:COO)

Sagespring Wealth Partners LLC bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) during the fourth quarter, HoldingsChannel reports. The firm bought 2,650 shares of the medical device company’s stock, valued at approximately $244,000.

A number of other large investors also recently modified their holdings of COO. JPMorgan Chase & Co. lifted its stake in shares of Cooper Companies by 1.5% in the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock valued at $460,066,000 after buying an additional 74,501 shares in the last quarter. Geode Capital Management LLC increased its holdings in Cooper Companies by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock worth $449,907,000 after purchasing an additional 109,907 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company’s stock worth $415,985,000 after purchasing an additional 574,899 shares during the last quarter. Norges Bank bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $217,906,000. Finally, FMR LLC boosted its position in shares of Cooper Companies by 97.6% during the fourth quarter. FMR LLC now owns 2,218,112 shares of the medical device company’s stock valued at $203,911,000 after buying an additional 1,095,805 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Stock Up 0.6 %

COO stock opened at $78.23 on Thursday. The Cooper Companies, Inc. has a fifty-two week low of $69.81 and a fifty-two week high of $112.38. The stock has a fifty day moving average of $83.62 and a 200-day moving average of $94.08. The company has a market capitalization of $15.64 billion, a price-to-earnings ratio of 40.12, a PEG ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have weighed in on COO shares. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Friday, March 7th. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research report on Friday, March 7th. Piper Sandler reaffirmed an “overweight” rating and set a $115.00 price target (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Citigroup reduced their price objective on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Finally, Stifel Nicolaus cut their price target on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.